Emergent BioSolutions (EBS) Liabilities from Discontinued Operations (2015 - 2025)

Emergent BioSolutions' Liabilities from Discontinued Operations history runs 4 years deep, the most recent figure standing at 4500000.0 for Q3 2025.

• In Q3 2025, Liabilities from Discontinued Operations changed N/A year-over-year to 4500000.0; the TTM figure through Sep 2025 stood at 4500000.0 (changed N/A YoY), while the FY2015 annual figure was 17348000.0, changed N/A from the prior year.
• Liabilities from Discontinued Operations for Q3 2025 stood at 4500000.0, down from 4700000.0 in the prior quarter.
• The five-year high for Liabilities from Discontinued Operations was 37500000.0 in Q1 2023, with the low at 4500000.0 in Q3 2025.
• The 3-year median for Liabilities from Discontinued Operations is 4800000.0 (2025), against an average of 12320000.0.
• Peak annual rise in Liabilities from Discontinued Operations reached 53.47% in 2025, while the deepest fall reached 53.47% in 2025.
• Emergent BioSolutions' Liabilities from Discontinued Operations stood at 37500000.0 in 2023, then plunged by 73.07% to 10100000.0 in 2024, then slumped by 55.45% to 4500000.0 in 2025.
• Business Quant data shows EBS's Liabilities from Discontinued Operations at 4500000.0 in Q3 2025, 4700000.0 in Q2 2025, and 4800000.0 in Q1 2025.